Drug reactions. XVI. Lichenoid drug eruptions.
D000636:Aminosalicylic Acids / Q000009:adverse effects; D000814:Aniline Compounds / Q000506:poisoning; D001153:Arsphenamine / Q000009:adverse effects; D002740:Chlorothiazide / Q000009:adverse effects; D002747:Chlorpropamide / Q000009:adverse effects; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008010:Lichen Planus / Q000139:chemically induced*; D008750:Methyldopa / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D011796:Quinacrine / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects; D013844:Thiazoles / Q000009:adverse effects
D000636:Aminosalicylic Acids; D000814:Aniline Compounds; D010640:Phenothiazines; D013844:Thiazoles; D006852:Hydrochlorothiazide; D001153:Arsphenamine; D008750:Methyldopa; D006046:Gold; D002740:Chlorothiazide; D013752:Tetracycline; D010653:Phenylbutazone; D011796:Quinacrine; D011802:Quinidine; D002747:Chlorpropamide